Short-chain fatty acids production enhancement

Short-chain fatty acids production enhancement" is not a specific molecule, receptor, enzyme, or canonical therapeutic target. Instead, it refers to the process of increasing the biosynthesis of short-chain fatty acids (SCFAs) by gut microbiota through fermentation of dietary fibers and resistant starches in the large intestine[1][2]. SCFAs—primarily acetate, propionate, and butyrate—are key metabolites that play important roles in maintaining intestinal barrier integrity[3], modulating immune responses[1], influencing energy metabolism[1][4], and mediating gut-brain communication[1]. Enhancement of their production can be achieved via dietary interventions or manipulation of microbial communities but does not correspond to a single molecular entity or druggable target. Therefore, this entry is considered incorrect as a therapeutic target because it describes a biological process rather than an individual molecule or receptor amenable to direct pharmacological modulation.

Other names

SCFA production enhancementincreased short-chain fatty acid synthesisenhanced SCFA generation